In this webinar, Mathys & Squire partners Stephen Garner and Anna Gregson explore the impact of clinical trials on the assessment of sufficiency and inventive step, while exploring recent EPO case law.
The European Patent Office’s strict approach to the assessment of written basis can be a potential minefield for applicants looking to amend around prior art. Partners Martin MacLean and David Hobson provide their tips and tricks to build into your drafting practice to safeguard against common pitfalls.
In this webinar, attorneys Jeremy Smith and Alexander Robinson take a look at the European Patent Office’s approach to the developing field AI in life sciences, including an overview of the fundamentals of AI together with case studies highlighting important issues for life sciences AI inventions in particular.
A new 2021 edition of the EPO Guidelines for Examination will come into effect in March 2021, with significant revisions regarding the requirement to amend the description for conformity with the claims expected. In this webinar, partners Hazel Ford and Andrew White discuss the potential implications of these changes.
In this webinar, partners Sean Leach, Andrew White and Juliet Redhouse discuss some of the relatively under-used and cost-effective options available to practitioners in challenging third party patents and patent applications both pre- and post-grant.
In this webinar, Mathys & Squire partners Andreas Wietzke and Andrew White are joined by IP specialist barrister Edward Cronan from Hogarth Chambers to discuss recent Standard Essential Patent (SEP) litigation cases in Europe.
Our presenters, Stephen Garner and Anna Gregson, discuss how EPO case law has developed since revocation of the dasatinib patent in 2017, and explore how innovators should adjust their filing and drafting strategy in light of the EPO’s post-dasatinib approach to plausibility.
This webinar explores the different types of IP, including how to protect the value in your brands, confidentiality, NDAs and ownership, as well as how patents and registered designs are used in practice. Our presenters, Sam Giles and Harry Rowe, using a range of commercial case studies, illustrate the importance of IP to a business.
Now more than ever, businesses need to be resilient and plan for their future. Businesses must ensure that their IP strategy is aligned with their commercial goals, both to maximise profitability and to mitigate risk. This joint webinar with Hyperdrive, the NEAA and Mathys & Squire partners Sean Leach and Andrew White, explores how to do this in practice.
Following on from part one, in this webinar Mathys & Squire attorneys Peter Arch and Alexander Robinson take a closer look at controversies arising from recent case law, including whether SPCs can be granted for second medical indications, and how precisely the authorised product must be identified in a patent before being eligible for an SPC.
Trade mark downloads
See all our latest news
See all our upcoming events
View all newsletters
Sign up to our mailing list to receive Mathys Matters, our monthly newsletter covering the latest IP news, industry insights, events and case law.
If you are interested in receiving quarterly newsletters relevant to our core sector groups - IT & engineering ('Inside Wires') and life sciences & chemistry ('Under the Microscope') - please select your preference(s) below:
Please select your practice area(s) of interest: